A century of research.
One single field.

The BrainCode® Integrated Device introduces the corrective signal into the perineural semiconductor system that Szent-Györgyi identified as the organising substrate of physiology.

The BrainCode® Integrated Device operates on the same perineural semiconductor system. The bioenergetic testing reads the DC currents that Becker measured.

The EMF category in BrainCode® frequency vectors arises directly from this work: it identifies artificial EM fields as primary interferents of the biological semiconductor system.

The BrainCode® bioenergetic test detects alterations in the electrodynamic field before they manifest as symptoms — exactly the pre-symptomatic level that Burr documented for 44 years.

The BrainCode® Protocol acts on the Living Matrix: every correction introduced by paravertebral neuromodulation propagates through the entire semiconductor connective network.

Paravertebral neuromodulation operates exactly on the circuit that Tennant describes: it restores bioelectric coherence to the system that powers cellular voltage.

The "electrome" Adee describes is the operational level of BrainCode®: the protocol reads and corrects interferences in the bioelectric field that regulates every biological function.

Lakhovsky's intuition on the cell as an oscillating circuit prefigures the BrainCode® operational principle: the field of every cell can be recalibrated through a specific frequency signal in counter-phase.

The BrainCode® bioenergetic testing operates on the same field of intercellular electromagnetic communication that Popp measured: every interference alters biophoton coherence before manifesting as symptom.

EZ water is the physical substrate in which the BrainCode® corrective signal propagates: the imprinting in the output vials exploits the ability of structured water to retain electromagnetic information.

QED coherence domains are the physical mechanism underlying imprinting in the BrainCode® Integrated Device: the corrective signature is stably inscribed in the coherent water of the output vials.

Citro's Electronic Transfer is the founding experimental demonstration of the physical principle on which BrainCode® imprinting operates: electromagnetic information is transferable and biologically active.

Schrödinger's negentropy is the conceptual framework in which BrainCode® operates: the protocol restores informational order in a biological system that has temporarily lost coherence.

The field McTaggart synthesises is the informational substrate on which BrainCode® operates: the bioenergetic testing reads it, the Integrated Device modifies it, the paravertebral protocol restores coherence.

Morphic resonance offers a theoretical framework for understanding how the BrainCode® corrective signal, introduced at the paravertebral level, reorganises patterns of response at the systemic level.

Faggin's CIF framework provides the ontological foundation in which BrainCode® operates: consciousness, information and field are inseparable — the protocol acts precisely on their interface.

BrainCode® bioenergetic testing expands the logic that Clark introduced: it identifies interferences (pathogens, toxins, dysfunctional patterns) through the response of the bioelectric field, in a pre-biochemical reading.

Allegretti's work contextualises BrainCode® within the broader family of electromagnetic therapies, from which it distinguishes itself for the specificity of paravertebral phase correction amplified 1000×.

Hennecke's study validates the physical principle of BrainCode®: electronic counter-phase as a method for neutralising pathological interferences — the method BrainCode® applies with greater specificity and amplification.

BioSET has clinically validated the fundamental principle: bioenergetic desensitisation works through paravertebral stimulation on an identified interference. BrainCode® extends the method with 1000× amplification and specific frequency correction.

Walsh documents how biochemistry responds to targeted interventions. BrainCode® operates upstream: it modulates the bioelectric field that regulates enzymatic expression — modifying biochemistry at the level that generates it.

Amino acids are molecular substrates for paravertebral neuromodulation: BrainCode® operates on the bioelectric field that regulates their metabolism and use, while Bianchi's work addresses the molecular level.

NAET demonstrated that allergic/intolerance responses can be resolved through non-pharmacological energetic interventions. BrainCode® expands the logic with counter-phase frequency correction at the paravertebral level.

Pert documents the biochemical substrate on which BrainCode® operates at the field level: the paravertebral protocol modulates the bioelectric component of the network that generates and regulates emotions.

The "epigenetic pianist" Restian describes is the system on which BrainCode® operates: the paravertebral protocol introduces a coherent electromagnetic signal that modulates genetic expression at the level of the regulatory field.

The quantum physics Gheorghiu synthesises is the theoretical framework of the BrainCode® method: non-locality, coherence and information are the operational principles of the protocol.

The Primary Vascular System identified by Proietti is the anatomical substrate on which BrainCode® operates: the paravertebral protocol introduces the corrective signal exactly into the circuits that Proietti mapped.

The authors describe the exact physical mechanism of the BrainCode® Protocol: amplified electromagnetic phase correction as a therapeutic intervention on living systems — authorised and clinically validated research.